 |
 |
 |
|
 |
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | FDA Centennial
The meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for February 20, 2008, is cancelled. This meeting was announced in the Federal Register of December 21, 2007 (72 FR pages 72737, 72738).
CONTACT:
Teresa A. Watkins, Center for Drug Evaluation and Research, 301-827-7001, fax:
301-827-6776, e-mail: teresa.watkins@fda.hhs.gov,
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in
the Washington, DC area), code 3014512545.